[Meningeal carcinomatosis in cancer patients].
Danova
Marco
M
Unità di Citometria e Terapie Cellulari, Oncologia Medica, Università e IRCCS San Matteo, Pavia.
Invernizzi
Roberta
R
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary*; D003561:Cytarabine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D008577:Meningeal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary*; D008727:Methotrexate / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D008727:Methotrexate